2026 Interim Report
Filed with HKEX · Stock code 882 · · 57 pages · English
Summary by 6ix AI
The report includes condensed consolidated financial statements, highlighting revenue, profit, and other key financial metrics compared to the previous year. It also outlines the company's business structure across various sectors, including utilities, pharmaceuticals, and hotels. The financial statements are prepared in accordance with Hong Kong Accounting Standards and include a review of the company's accounting policies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Tianjin Development Holdings Limited on 6ix
Earlier from Tianjin Development
- Completion of Change of Shareholding Structure of Intermediate Controlling Shareholder of the Company and Continuing Connected Transactions
- General Mandates to Issue Shares and to Buy Back Shares, Re-election of Directors and Notice of Annual General Meeting
- Change of Shareholding Structure of Intermediate Controlling Shareholder
- Discloseable Transaction - Subscriptions of Wealth Management Products
- Discloseable and Connected Transaction - Disposal of the Entire Equity Interest in Tianjin Heavenly Palace Winery Co., Ltd. and Notice of Extraordinary General Meeting
Later from Tianjin Development
- Notification Letter to Existing Shareholders and Request Form
- Notification Letter to Non-registered Shareholders and Request Form
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Unaudited Financial Results for the nine months ended 30 September 2026 of Tianjin Lisheng Pharmaceutical Co., Ltd.
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Tianjin Development into a list and get an email when it puts out news.
Follow Tianjin Development